Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05548517
Other study ID # Pro2021002434
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 15, 2022
Est. completion date September 2025

Study information

Verified date October 2023
Source Rutgers, The State University of New Jersey
Contact Prinicipal Investigator
Phone 848-932-9403
Email shapses@rutgers.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.


Description:

Time-restricted eating (TRE) has gained increased attention due to the possibility to induce weight loss and improve cardiometabolic health as a result of the purported alignment of circadian rhythm. However, since TRE is often reported to cause a spontaneous reduction of calories, it is not well understood if these health benefits are due to weight loss, circadian rhythm alignment, or a combination of the two. Furthermore, while weight loss can improve cardiometabolic health, it can also induce bone loss, which is problematic in older women who are at a higher risk of fracture. Interestingly, both bone turnover and the gut microbiota are responsive to diurnal variations, such as meal timing, and alterations in the gut microbiota have been associated with differences in bone health. In rodent models, caloric restriction can alter the gut microbiota composition with further alterations shown due to time-restricted eating. This suggests that time-restricted eating could affect bone health, which may be partially mediated by changes in the gut microbiota. Also, lifestyle patterns affects both the microbiota and bone. This randomized controlled trial will use behavior modification to examine TRE plus caloric restriction (CR) to achieve an evening energy deficit compared to CR alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date September 2025
Est. primary completion date September 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 50 Years to 79 Years
Eligibility Inclusion Criteria: - Postmenopausal women (>2 years since last menses) - Body mass index (25-45 kg/m2) - Agree to be randomly assigned to consume food for = 9 hours/day or =12 hours/day - Must attend on-site visits (about 10) in New Brunswick, NJ, USA (transportation/reimbursement for travel not included) Exclusion Criteria: - Participants with >5% weight loss in the past 6 months or extreme dietary/physical activity habits - An inability to follow the experimental intervention or to perform the required specimen collections - Antibiotic use in the past 2 months - Current diagnosis, or history of cancer in past 3 years - History of surgical procedure for weight loss in the past 3 years - Current diagnosis or history of bone diseases, type I or II diabetes, gastrointestinal disease, hyperparathyroidism, untreated thyroid disease, significant immune, hepatic, cardiac, or renal disease - Uncontrolled hypertension or hyperlipidemia in abnormal ranges - Regular use of medications that affect bone metabolism, including bisphosphonates or hormone replacement. - A colonoscopy within the past 2 months - Alcohol or illicit drug abuse - Current smoker or having quit smoking in the past 3 months - Shift work - Participation in another clinical research trial which may interfere with the results of this study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Time Restricted Eating (TRE)
9-hour eating window
Calorie Restriction
daily calorie restriction

Locations

Country Name City State
United States Rutgers University - NJ Inst Food Nutrition & Health New Brunswick New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other 25-hydroxyvitamin D (25OHD) serum change from baseline to an average 6 months
Other estradiol serum change from baseline to an average 6 months
Other parathyroid hormone (PTH) serum change from baseline to an average 6 months
Other Fasting osteocalcin serum bone formation and energy marker change from baseline to an average 6 months
Other Fasting procollagen type 1 N-terminal propeptide (PINP) serum bone formation marker change from baseline to an average 6 months
Other Fasting C-telopeptide of type I collagen (CTX) serum bone resorption marker change from baseline to an average 6 months
Other Cognitive function Cambridge Neuropsychological Test Automated Battery change from baseline to an average 6 months
Other melatonin serum change from baseline to an average 6 months
Other cortisol serum change from baseline to an average 6 months
Other Quality of sleep Pittsburgh sleep quality index (0-21; higher score is worse) change from baseline to an average 6 months
Other Diet quality score nutrient analysis software (Healthy Eating Index 0-100; higher score is better) change from baseline to an average 6 months
Other Eating self-efficacy Weight lifestyle efficacy questionnaire short-form (0-80; higher score is better) change from baseline to an average 6 months
Other Circumferences tape measure (waist, hip and thigh) change from baseline to an average 6 months
Other Short physical performance battery (SPPB) Total score of SPPB (0-12; higher score is better) change from baseline to an average 6 months
Other 6 minute walk test total distance change from baseline to an average 6 months
Other Timed up and go total time change from baseline to an average 6 months
Other Hand Grip dynanometer (isometric grip force) change from baseline to an average 6 months
Primary Weight loss Body weight in kg change from baseline to an average 6 months
Primary Bone mineral density (BMD - hip) dual energy x-ray absorptiometry change from baseline to an average 6 months
Primary Microbiota stool change from baseline to an average 6 months
Secondary Soft tissue (lean and fat mass) dual energy x-ray absorptiometry change from baseline to an average 6 months
Secondary Areal BMD (lumbar spine, femoral neck, radius, total body) dual energy x-ray absorptiometry change from baseline to an average 6 months
Secondary Trabecular bone (volumetric BMD, bone volume / total volume, and separation) peripheral quantitative computed tomography change from baseline to an average 6 months
Secondary Cortical bone (volumetric BMD, thickness, and porosity) and total BMD peripheral quantitative computed tomography change from baseline to an average 6 months
Secondary Blood pressure (systolic and diastolic) sphygmomanometer change from baseline to an average 6 months
Secondary Glucose - response to oral glucose tolerance test fasting and response to glucose solution change from baseline to an average 6 months
Secondary Insulin - response to oral glucose tolerance test fasting and response to glucose solution change from baseline to an average 6 months
See also
  Status Clinical Trial Phase
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Terminated NCT03316105 - Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers N/A
Completed NCT03700736 - The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups N/A
Active, not recruiting NCT04353726 - Knowledge-based Dietary Weight Management. N/A
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02877004 - LLLT for Reducing Waste Circumference and Weight N/A
Active, not recruiting NCT04327141 - Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women N/A
Completed NCT03929198 - Translation of Pritikin Program to the Community N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Recruiting NCT05942326 - Sleep Goal-focused Online Access to Lifestyle Support N/A
Completed NCT00535600 - Effects of Bariatric Surgery on Insulin
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Active, not recruiting NCT04357119 - Common Limb Length in One-anastomosis Gastric Bypass N/A
Completed NCT02945410 - Effect of Caloric Restriction and Protein Intake on Metabolism and Anabolic Sensitivity N/A
Completed NCT03210207 - Gastric Plication in Mexican Patients N/A
Completed NCT03139760 - POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability N/A
Completed NCT02948517 - Time Restricted Feeding for Weight Loss and Cardio-protection N/A
Recruiting NCT02559479 - A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes N/A